Merck logo
Merck
MKKGY | OTC
Chart Builder DCF Calculator
$32.78
-$0.29 (-0.88%)
At close: Nov 16, 2026, 3:53 PM ET
$32.73
-$0.05 (-0.15%)
After-hours: Nov 16, 2026, 3:37 PM ET

Merck Company Profile

Company profile explained

Company Profile

Merck KGaA is a leading German science and technology enterprise. Its business operations are strategically organized into three core divisions: Life Science, Healthcare, and Electronics. The Life Science segment provides an extensive portfolio of tools, chemicals, and equipment essential for academic research laboratories, biotech firms, pharmaceutical manufacturers, and the broader industrial sector. This division also furnishes drug developers with specialized process development expertise and advanced technologies, such as continuous bioprocessing, alongside a variety of testing kits, reagents, and associated services. Furthermore, it delivers analytical solutions for environmental monitoring (air, water, and soil) and products designed to evaluate nutritional content and detect quality deviations. The Healthcare segment focuses on the discovery, development, manufacturing, and commercialization of prescription drugs and biopharmaceuticals. Its therapeutic areas encompass oncology, neurology and immunology, fertility, endocrinology, cardiovascular conditions, diabetes, thyroid disorders, and multiple sclerosis. This segment also markets general medicines and integrates medical technology, including injection devices and disease monitoring software. The Electronics segment supplies critical materials to the semiconductor and display industries. It also specializes in surface design solutions, offering comprehensive delivery systems, services, and innovative surface products, which include cosmetic ingredients, effect pigments, and various functional applications. Beyond its internal operations, Merck KGaA actively pursues strategic collaborations. This includes in-licensing agreements, such as with Debiopharm International SA for drug candidates targeting head and neck cancer; with Jiangsu Hengrui Pharmaceuticals Co. Ltd. for treatments against metastatic colorectal cancer; and with Abbisko Therapeutics Co. Ltd. for therapies for tenosynovial giant cell tumor. The company also holds a license and collaboration agreement dedicated to identifying two targeted protein degraders for vital oncogenic proteins. Established in 1668, Merck KGaA boasts a long and distinguished history and is headquartered in Darmstadt, Germany. The company functions as a subsidiary under the umbrella of E. Merck KG.

Key Executives

Name Position
Benjamin Hein Member of Management Board & CEO of Electronics Business Sector
Danny Pinhas Bar-Zohar Member of the Executive Board & Chief Executive Officer of Healthcare
Jean Charles Wirth Member of the Executive Board & Chief Executive Officer Life Science
Kai Beckmann CEO & Chair of Management Board
Helene von Roeder Chief Financial Officer & Member of Executive Board
Khadija Ben Hammada Member of the Executive Board & Chief People Officer
Axel Lober Head of Global Communications
Florian Schraeder Head of Investor Relations
Frank Gotthardt Head of Corporate & Government Relations - Europe
Marc Horn Head of Life Science Controlling
Merck
Merck logo
Country Germany
IPO Date Nov 16, 2007
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 62,461
CEO Kai Beckmann

Contact Details

Frankfurter Strasse 250 Darmstadt, HE 64293 Germany

Stock Details

Ticker Symbol MKKGY
Exchange OTC
Fiscal Year n/a
Reporting Currency USD
CIK Code n/a
CUSIP Number 589339209
ISIN Number US5893392093
SIC Code n/a

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.